This topic contains a solution. Click here to go to the answer

Author Question: The Dietary Reference Intakes (DRIs) differ according to A. an individual's age and gender. B. ... (Read 64 times)

Bernana

  • Hero Member
  • *****
  • Posts: 530
The Dietary Reference Intakes (DRIs) differ according to
 
  A. an individual's age and gender.
  B. an individual's height and weight.
  C. an individual's age and weight.
  D. an individual's gender and height.

Question 2

The Recommended Dietary Allowance (RDA. for nutrients is generally
 
  A. specific for the nutrient needs for minerals only.
  B. designed to meet the needs of nearly all (97 to 98 percent. of the individuals in a similar group.
  C. the same for all genders and ages.
  D. all of the above.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

lindahyatt42

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

ANS: A

Answer to Question 2

ANS: B




Bernana

  • Member
  • Posts: 530
Reply 2 on: Aug 20, 2018
Excellent


milbourne11

  • Member
  • Posts: 322
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

Did you know?

Human kidneys will clean about 1 million gallons of blood in an average lifetime.

Did you know?

Adolescents often feel clumsy during puberty because during this time of development, their hands and feet grow faster than their arms and legs do. The body is therefore out of proportion. One out of five adolescents actually experiences growing pains during this period.

Did you know?

According to the National Institute of Environmental Health Sciences, lung disease is the third leading killer in the United States, responsible for one in seven deaths. It is the leading cause of death among infants under the age of one year.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library